Ingelvac Provenza™: Administration

Ingelvac Provenza™ offers optimized intranasal administration of IAV-S vaccine

Intranasal administration stimulates mucosal immunity at the natural site of infection by influenza A virus in swine (IAV-S).^1,2

Intranasal protection where IAV-S infection starts

Nozzle designed for optimized delivery.

Customized nozzle delivers vaccine as a mist appropriate for optimized delivery on respiratory mucosal surfaces.*

AVAILABLE IN A 50-DOSE PRESENTATION.

Ingelvac Provenza™ 50 dose presentation photo

DIRECTIONS AND DOSAGE PRECAUTIONS

Intranasal vaccine administration

Administración de vacuna intranasal

AVAILABLE IN A 50-DOSE PRESENTATION.

DIRECTIONS AND DOSAGE PRECAUTIONS

* Complimentary Neogen® Prima® Mist nozzle must be listed by separate product code when ordering.

Neogen and Prima are registered trademarks of Neogen Corporation.

References: 1. Vincent AL, Ma W, Lager KM, et al. Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine. Vaccine. 2007;25:7999–8009. 2. Janke BH. Influenza A virus infections in swine: pathogenesis and diagnosis. Vet Pathol. 2014;51:410–426.